ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Pharsight Corp (MM)

Pharsight Corp (MM) (PHST)

5.48
0.00
(0.00%)
Closed September 20 4:00PM
5.48
0.00
( 0.00% )
Pre Market: 8:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
5.48
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
5.48
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

PHST Latest News

Pharsight Launches PK Accelerator(TM)

PK Accelerator Bundled Solution Accelerates Pharmacokinetic Analysis and Reporting MOUNTAIN VIEW, Calif., June 24 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading...

Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference

Talk Will Cover the Use of Pharsight Software for In-Vitro / In-Vivo Correlation Modeling in Drug Development MOUNTAIN VIEW, Calif., June 23 /PRNewswire-FirstCall/ -- Pharsight(R) Corporation...

Pharsight to Present on Literature-Based Disease Modeling Approaches at AAPS National Biotechnology Conference

Dr. Farkad Ezzet Will Present on the Strategic Value of Literature Modeling to Assess Disease Progression and Drug Attributes in Clinical Development MOUNTAIN VIEW, Calif., June 17...

Pharsight to Present on Oncology Modeling and Simulation at PAGE Annual Meeting

Dr. Laurent Claret Will Present Case Studies on the Value of Drug-Disease Modeling to Predict Efficacy and Survival Benefits of Anticancer Agents MOUNTAIN VIEW, Calif., June 12...

Pharsight to Present on Its Vision for Modeling and Simulation Software at PAGE Annual Meeting

Dr. Robert Leary Will Discuss Computational Methods for Model Evaluation; Dr. Mike Dunlavey Will Present Simplified Programming Approaches of Population Model User Interfaces MOUNTAIN VIEW...

Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress

Dr. Helen Kastrissios Will Present on Communicating the Value of Pharmacodynamic Modeling in Clinical Drug Development MOUNTAIN VIEW, Calif., May 27 /PRNewswire-FirstCall/ -- Pharsight...

Pharsight Hosts European PKS User Meeting

Second Annual European Meeting to be Held In Paris MOUNTAIN VIEW, Calif., May 23 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading provider of software, strategic...

Pharsight Achieves $7.6 Million In Quarterly Revenue

Fourth Quarter Revenue Highest in Company History; Full Year Revenue Up 13% MOUNTAIN VIEW, Calif., May 8 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading provider of...

Pharsight Invited to Present on Antiviral Modeling and Simulation at DIA Adherence Workshop

Dr. Bill Poland Will Present on the Strategic Use of Incorporating Adherence Data into Clinical Trial Predictions of Antiviral Therapies MOUNTAIN VIEW, Calif., April 30 /PRNewswire-FirstCall/...

Pharsight Strengthens Senior Management Team

John Murphy Appointed as New Senior Vice President of Consulting Services MOUNTAIN VIEW, Calif., April 29 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading provider of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NVVENuvve Holding Corporation
$ 7.70
(96.43%)
3.9M
SOXMTradr 2X Long SOXX Monthly ETF
$ 36.96
(58.98%)
52
NUKKNukkleus Inc
$ 0.3174
(49.36%)
17.54M
TGLTreasure Global Inc
$ 0.9119
(34.04%)
2.02M
LGHLWLion Group Holding Ltd
$ 0.008
(33.33%)
626
ZJYLJin Medical International Ltd
$ 3.14
(-23.04%)
38.55k
AACGATA Creativity Global
$ 0.40
(-21.61%)
1
SMXTSolarMax Technology Inc
$ 0.7029
(-19.75%)
214
ADTXAditxt Inc
$ 0.3101
(-18.95%)
75.85k
CJETChijet Motor Company Inc
$ 2.28
(-18.57%)
793
NUKKNukkleus Inc
$ 0.3174
(49.36%)
17.54M
LGCBLinkage Global Inc
$ 0.5381
(28.64%)
12.31M
MAXNMaxeon Solar Technologies Ltd
$ 0.0812
(-11.26%)
4.15M
NVVENuvve Holding Corporation
$ 7.70
(96.43%)
3.9M
GSIWGarden Stage Ltd
$ 1.68
(25.37%)
3.87M

PHST Discussion

View Posts
No Posts Found

Your Recent History

Delayed Upgrade Clock